Buchumschlag

Distinguishing chronic disease profiles and cause of death attribution in opioid and or stimulant toxicity deaths to inform overdose prevention efforts

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Heather Palis, Jennifer Vincent, Juls Budau, Kevin Hu, Andrew Tu
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	Addiction
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Refining cause of death attribution among opioid, opioid‐stimulant and stimulant acute toxicity deaths
von: Yi‐Shin Grace Chang, et al.
Veröffentlicht: (2025)

Association between prescribed stimulant medications and overdose among individuals receiving opioid agonist therapy: A retrospective cohort study from British Columbia, Canada
von: Samantha Young, et al.
Veröffentlicht: (2025)

Impact of enhanced practices on opioid overdose deaths: A community‐based modeling approach
von: Carolina Barbosa, et al.
Veröffentlicht: (2026)

Clinical characteristics of heroin overdose deaths among older adults in Australia, 2000–2025
von: Shane Darke, et al.
Veröffentlicht: (2025)

Distributions of alcohol use and alcohol‐caused death and disability in Canada: Defining alcohol harm density functions and new perspectives on the prevention paradox
von: Adam Sherk, et al.
Veröffentlicht: (2024)

Clinical factors linked to xylazine exposure in emergency department patients with illicit opioid overdose
von: Jennifer S. Love, et al.
Veröffentlicht: (2026)

Predictors of emergency medical transport refusal following opioid overdose in Washington, DC
von: Ben Turley, et al.
Veröffentlicht: (2024)

Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–2021
von: Abenaa A. Jones, et al.
Veröffentlicht: (2024)

Health care service utilization and drug overdose death: A national nested case–control registry study
von: Linn Gjersing, et al.
Veröffentlicht: (2024)

Commentary on Stam et al .: The substantial and dynamic contribution of opioid potency to total overdose risk
von: Phillip O. Coffin
Veröffentlicht: (2024)

Brief report: A cross‐sectional survey of provider engagement with family members following patient drug overdose death
von: Jessica B. Calihan, et al.
Veröffentlicht: (2026)

Among people who use heroin, tobacco smoking and illegal drugs cause a similar number of premature deaths
von: Dan Lewer, et al.
Veröffentlicht: (2025)

Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type
von: Corey J. Hayes, et al.
Veröffentlicht: (2024)

Characteristics of deaths due to drug‐related causes among individuals recently released from prison in the United Kingdom, 1997–2025
von: Emmert Roberts, et al.
Veröffentlicht: (2026)

Heightened mortality risk after a non‐fatal opioid overdose: Risk factors for mortality in the week following emergency treatment
von: Desiree Eide, et al.
Veröffentlicht: (2024)

Associations among social determinants of health and opioid use disorder and overdose: An umbrella review
von: Lauren B. Loeffel, et al.
Veröffentlicht: (2026)

Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review
von: Philipa Owusu‐Antwi, et al.
Veröffentlicht: (2025)

Underage deaths associated with substance‐related harm in Taiwan: A national 10‐year study
von: Shyh‐Yuh Wei, et al.
Veröffentlicht: (2026)

A descriptive analysis of rural‐urban overdose experiences among incarcerated women with opioid use disorder
von: Megan F. Dickson, et al.
Veröffentlicht: (2025)

Commentary on Young et al .: Clinical guidance is required for stimulant co‐prescription with opioid agonist therapy
von: Nadine Ezard, et al.
Veröffentlicht: (2025)

Corrigendum to “Incremental expenditures attributable to daily dispensation and witnessed ingestion for opioid agonist treatment in British Columbia: 2014–20”
Veröffentlicht: (2024)

Commentary on Gregory et al .: Fear of precipitated opioid withdrawal should not prevent buprenorphine initiation
von: Sandra A. Springer
Veröffentlicht: (2024)

Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference‐in‐differences time series
von: Nathaniel Day, et al.
Veröffentlicht: (2026)

Commentary on Ezard et al.: Agonist‐based medications for stimulant use disorder—Distinguishing their true colours
von: Vitor S. Tardelli, et al.
Veröffentlicht: (2025)

Characteristics of drug‐related deaths among individuals identified as LGBTQ+ in the United Kingdom, 1997–2024
von: Emmert Roberts, et al.
Veröffentlicht: (2025)

Differences in heroin overdose risk associated with the unregulated drug market: Insights from a supervised injecting facility in Melbourne, Australia
von: Nathan C. Stam, et al.
Veröffentlicht: (2024)

Changing trends in drug overdose mortality in Spain, 2001–2022
von: Florencia Giné, et al.
Veröffentlicht: (2025)

A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)‐ and psilocybin‐related death in Australia
von: Shane Darke, et al.
Veröffentlicht: (2024)

Prevalence of problematic pharmaceutical opioid use in patients with chronic non‐cancer pain: A systematic review and meta‐analysis
von: Kyla H. Thomas, et al.
Veröffentlicht: (2024)

Response to Crockford et al .: Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference‐in‐differences time series
von: Nathaniel Day, et al.
Veröffentlicht: (2026)

Clarifying Selected Citations and Interpretations in ‘Underage deaths associated with substance‐related harm in Taiwan: A national 10‐year study’
von: Jia‐Min Yang, et al.
Veröffentlicht: (2026)

Fatal drug overdoses in healthcare workers: A thematic framework analysis of coroner reports
von: Thikra Algahtani, et al.
Veröffentlicht: (2025)

Prevalence of adults with stimulant misuse and/or stimulant use disorder in Massachusetts, USA, 2014–2021
von: Joshua A. Barocas, et al.
Veröffentlicht: (2024)

Quantifying the impact of a large‐scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data‐modeling study
von: Thomas James Santo, et al.
Veröffentlicht: (2025)

Use and perceptions of involuntary civil commitment among post‐overdose outreach staff in Massachusetts, United States: A mixed‐methods study
von: Emily R. Cummins, et al.
Veröffentlicht: (2024)

Commentary on Giné et al .: The hidden face of overdose: Gender inequities along the continuum of care
von: Patrizia Carrieri, et al.
Veröffentlicht: (2025)

Inequities in naloxone administration among fatal overdose decedents by race and ethnicity in Pennsylvania, 2019–21
von: Erin Takemoto, et al.
Veröffentlicht: (2024)

The Opioid Safety Toolkit: An interactive prescription opioid safety toolkit to increase opioid safety literacy and behaviours among people prescribed opioids for pain—a randomised controlled trial
von: Suzanne Nielsen, et al.
Veröffentlicht: (2026)

Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all‐cause mortality among people with opioid use disorder: A retrospective population‐based target trial emulation study in British Columbia, Canada, 2010–2020
von: Ruyu Yan, et al.
Veröffentlicht: (2026)

Cannabis and the overdose crisis among US adolescents
von: Archie Bleyer, et al.
Veröffentlicht: (2024)